Tussin Cf
NDC Package 76140-105-08

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Tussin Cf is do not take more than 6 doses in any 24-hour periodthis adult product is not intended for use in children under 12 years of agemL = milliliter; tsp = teaspoonfulagedoseadults and children 12 years and over10 mL (2 tsp) every 4 hourschildren under 12 yearsdo not use. Marketed by Davagen Pharmaceutical, Llc, this product is identified by NDC 76140-105 and is authorized under FDA application part341.

Identification & Billing

NDC Package Code
76140-105-08
Package Description
1 BOTTLE, PLASTIC in 1 CARTON / 236 mL in 1 BOTTLE, PLASTIC
Product Code
76140-105
11-Digit Billing Format
76140010508
RxNorm Crosswalk
  • RxCUI: 1044949 - dextromethorphan HBr 20 MG / guaiFENesin 200 MG / phenylephrine HCl 10 MG in 10 mL Oral Solution
  • RxCUI: 1044949 - dextromethorphan hydrobromide 2 MG/ML / guaifenesin 20 MG/ML / phenylephrine hydrochloride 1 MG/ML Oral Solution
  • RxCUI: 1044949 - dextromethorphan HBr 10 MG / guaifenesin 100 MG / phenylephrine HCl 5 MG per 5 ML Oral Solution
  • RxCUI: 1044949 - dextromethorphan HBr 20 MG / guaifenesin 200 MG / phenylephrine HCl 10 MG per 10 ML Oral Solution

Clinical Specifications

Proprietary Name
Tussin Cf
Dosage Form
-
Usage Information
Do not take more than 6 doses in any 24-hour periodthis adult product is not intended for use in children under 12 years of agemL = milliliter; tsp = teaspoonfulagedoseadults and children 12 years and over10 mL (2 tsp) every 4 hourschildren under 12 yearsdo not use

Regulatory & Marketing

Labeler Name
Davagen Pharmaceutical, Llc
FDA Application #
part341
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
04-10-2013
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 76140-105-08 identifies a specific commercial package of 1 bottle, plastic in 1 carton / 236 ml in 1 bottle, plastic of Tussin Cf, labeled by Davagen Pharmaceutical, Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Davagen Pharmaceutical, Llc on April 10, 2013. The current certification is valid through December 31, 2017.

How is this Davagen Pharmaceutical, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 76140010508. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
76140-105-08
11-Digit CMS (5-4-2)
76140-0105-08

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.